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Abstract
Background: In higher eukaryotes DNA methylation regulates important biological functions
including silencing of gene expression and protection from adverse effects of retrotransposons. In
the protozoan parasite Entamoeba histolytica, a DNA methyltransferase has been identified and
treatment with 5-azacytidine (5-AzaC), a potent inhibitor of DNA methyltransferase, has been
reported to attenuate parasite virulence. However, the overall extent of DNA methylation and its
subsequent effects on global gene expression in this parasite are currently unknown.
Results: In order to identify the genome-wide effects of DNA methylation in E. histolytica, we used
a short oligonucleotide microarray representing 9,435 genes (~95% of all annotated amebic genes)
and compared the expression profile of E. histolytica HM-1:IMSS parasites with those treated with
23 µM 5-AzaC for up to one week. Overall, 2.1% of genes tested were transcriptionally modulated
under these conditions. 68 genes were upregulated and 131 genes down regulated (2-fold change;
p-value < 0.05). Sodium-bisulfite treatment and sequencing of genes indicated that there were at
least two subsets of genes with genomic DNA methylation in E. histolytica: (i) genes that were
endogenously silenced by genomic DNA methylation and for which 5-AzaC treatment induced
transcriptional de-repression, and (ii) genes that have genomic DNA methylation, but which were
not endogenously silenced by the methylation. We identified among the genes down regulated by
5-AzaC treatment a cysteine proteinase (2.m00545) and lysozyme (52.m00148) both of which have
known roles in amebic pathogenesis. Decreased expression of these genes in the 5-AzaC treated
E. histolytica may account in part for the parasites reduced cytolytic abilities.
Conclusion:  This work represents the first genome-wide analysis of DNA-methylation in
Entamoeba histolytica and indicates that DNA methylation has relatively limited effects on gene
expression in this parasite.
Published: 05 January 2007
BMC Genomics 2007, 8:7 doi:10.1186/1471-2164-8-7
Received: 06 September 2006
Accepted: 05 January 2007
This article is available from: http://www.biomedcentral.com/1471-2164/8/7
© 2007 Ali et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
Page 2 of 19
(page number not for citation purposes)
Background
Methylation is an enzymatic modification of DNA that
occurs post replication and epigenetically contributes to
transcriptional regulation. Many important biological
processes are modulated by DNA methylation including
regulation of gene expression [1], development [2], and
control of retrotransposon elements [3]. DNA methyla-
tion is also responsible for maintenance of chromatin
structure [4] and inactivation of chromosome X in female
mammals [5]. DNA methyltransferases (DNMTs) catalyze
DNA methylation, which in humans and higher eukaryo-
tes occurs predominantly at the C5-cytosine (m5C) in
CpG dinucleotides [6]. DNA methylation can silence
genes by directly blocking the interaction of transcription
factors to their regulatory sequences [7,8]. DNA methyla-
tion can also attract methyl-binding protein, which
recruits histone deacetylases and histone methyltrans-
ferases, resulting in an inactive chromatin structure [9,10].
Defects in establishing or maintaining DNA methylation
patterns are associated with a number of human diseases
and conditions such as cancers [11], schizophrenia [12],
and aging [13].
Entamoeba histolytica is a protozoan parasite and the caus-
ative agent of amebic dysentery and amebic liver
abscesses. These diseases result in significant morbidity
and mortality worldwide, especially in developing coun-
tries, where an estimated 50 million cases of invasive ame-
biasis result in up to 100,000 deaths annually [14]. An
active DNA methyltransferase (Ehmeth) of the DNA meth-
yltransferase 2 (DNMT2) family has been characterized in
E. histolytica [15] and ribosomal DNA [15] and a heat
shock protein 100 (EHsp100) gene [16] have been shown
to be methylated in this parasite. Additionally, an amebic
protein which binds preferentially to methylated DNA has
recently been identified (E. histolytica methylated LINE
binding protein, EhMLBP) [17]. Importantly E. histolytica
strain HM-1:IMSS grown with 5-azacytidine (5-AzaC), a
potent inhibitor of DNA methyltransferase, had been
shown to have significantly reduced virulence in vitro and
in vivo [15]. Furthermore, the decrease in parasite viru-
lence was reversible upon removal of the drug, indicating
that drug exposure likely did not cause significant perma-
nent mutations in the E. histolytica genome sequence [15].
On the other hand, over expression of Ehmeth in E. histo-
lytica resulted in accumulation of multinucleated cells, up
regulation of heat shock protein 70 (HSP70) expression,
and resistance to oxidative stress [18]. All these findings
suggest that DNA methylation has important biological
functions in this parasite.
Information on the effects of DNA methylation in simple
eukaryotes is relatively limited. 5-AzaC treatment of
Trypanosoma cruzi epimastigotes in culture induces active
cell proliferation as evident from an increase in the cell
number and [3H-methyl] thymidine incorporation into
DNA [19]. DNA methylation increases during develop-
ment of Dictyostelium discoideum and DNA methyltrans-
ferase mutant cells exhibit morphological defects in late
development, indicating that DNA methylation has a reg-
ulatory role in Dictyostelium development [2]. In ciliates,
cytosine methylation occurs in transposon-like elements
in the course of macronuclear differentiation in Stylony-
chia lemnae [20] and 5-AzaC treatment induces encyst-
ment in Colpoda inflata [21].
Several microarray-based studies have demonstrated that
inhibition of promoter methylation by a drug that inhib-
its DNA methyltransferase results in altered gene expres-
sion [22-25]. In Arabidopsis thaliana transcriptional
profiling revealed that inhibition of DNA methylation by
5-Aza-2-deoxycytidine (5Aza-dC) altered the expression
of 1.6% of genes tested, with 73 being up-regulated and
52 down-regulated by more than 3 fold [26]. Similarly 5-
Aza-dC treatment of a human gastric cancer cell line
caused up-regulation of about 1.5% of the genes by at
least 16-fold [22]. Treatment of esophageal squamous car-
cinoma cells with 5 µM of 5-Aza-dC caused at least 3-fold
or more up regulation of 1.92% of 12,599 genes [24].
In order to identify the genome-wide effects of DNA
methylation on gene expression in E. histolytica, we per-
formed transcriptional profiling of parasites treated with
and without 5-AzaC. Using a short oligonucleotide micro-
array representing 9,435 of the predicted 9,938 open read-
ing frames from E. histolytica [27] we identified 199 genes
(2.1%) as being modulated at least 2-fold by 5-AzaC. Of
these, 68 genes were up-regulated and 131 genes down
regulated. These data indicate that epigenetic gene silenc-
ing is operational in E. histolytica although it does not
effect a large portion of the amebic genome.
Results
Treatment with 5-AzaC did not significantly affect 
parasite growth but reduced virulence in vitro
In order to elucidate the effects of inhibiting genomic
DNA methylation in E. histolytica, we grew parasites in 23
µM 5-AzaC for up to seven days with routine passaging
and assessed growth rates and in vitro virulence. We used
two different E. histolytica strains HM-1:IMSS and
200:NIH, both of which are considered virulent [28,29].
For E. histolytica HM-1:IMSS parasites exposed to 23 µM 5-
AzaC there was some reduced growth at day 2, compared
to the untreated control, however, the parasite numbers in
subsequent days were consistently equivalent (Figure 1A).
In E. histolytica 200:NIH treated with 23 µM 5-AzaC, we
did not observe any statistically significant effect on
growth for up to seven days compared to the untreated
control (Figure 1B). Additionally, we grew E. histolytica
HM-1:IMSS for five consecutive days without routine sub-BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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culturing, and did not observe any growth differences in
parasites grown with or without 23 µM 5-AzaC (see Addi-
tional file 1A). We could not reliably grow parasites for >5
days without subculturing due to overcrowding of the cul-
tures and parasite death. For the 200:NIH strain, the par-
asite numbers in 5-AzaC treated and untreated cultures
were also equivalent at all time points tested, up to day 5
(data not shown). Under these conditions, we assessed
the protein content per cell of E. histolytica HM-1:IMSS
parasites at days 2, 3, 4, and 5 of growth, and found that
there were no significant differences in protein content
per cell between drug treated and untreated parasites or
between parasites at different time points (see Additional
file 1B). Similar data were observed for the 200:NIH strain
(data not shown). We also grew the E. histolytica HM-
1:IMSS strain (± 23 µM 5-AzaC) with routine subculturing
every two days with an equal volume of culture medium
and parasites passed at each time. Under these conditions,
the growth of the parasites in 23 µM 5-AzaC was slightly
reduced at day 2, however the rate of growth was subse-
quently equivalent to the untreated control at days 4 and
6 (see Additional file 1C). Overall, these data indicate that
there is not a substantial and sustained effect on the
growth of the E. histolytica parasites for up to 6–7 days in
the presence of 23 µM 5-AzaC.
For both E. histolytica HM-1:IMSS and E. histolytica
200:NIH, 5-AzaC exposure for 3 or 7 days resulted in par-
asites that were reduced in virulence (52% or 63% of
untreated levels respectively at day 3 and 28% and 35% of
untreated levels respectively at day 7) (Figure 1C). Expo-
sure to 5-AzaC at 23 µM did not affect CHO cell viability
and addition of 23 µM 5-AzaC to the parasites at the time
of the CHO cell killing assay did not affect parasite viru-
lence (data not shown). Thus the reduction in ability of
the parasites to kill CHO cells was dependent on prior
exposure of the parasites to 5-AzaC. Although this was an
in vitro cell killing assay and thus an indirect measure of
parasite virulence, our results correlate with previously
published data of in vitro and in vivo virulence attenuation
in E. histolytica HM-1:IMSS grown with 23 µM of 5-AzaC
for 1 week [15,16]. Since E. histolytica parasite strains are
genomically diverse (as shown by comparative genomic
hybridizations) [30] and have genome-wide expression
differences [31], it was not clear if the effects of 5-AzaC
could be generalized to other E. histolytica strains. We have
now shown that two genetically distinct, but virulent,
strains of E. histolytica, are similarly attenuated in their vir-
ulence potential by 5-AzaC treatment. Whether this viru-
lence attenuation is due to a direct effect of the 5-AzaC on
E. histolytica genomic DNA methylation, is due to some
other effect on the parasite, or is simply an associative
phenomenon, cannot be definitively stated at present.
Microarray expression profiling reveals genes modulated 
by 5-AzaC treatment
In order to identify genes whose expression was modu-
lated by 5-AzaC treatment, expression profiling of 9,435
amebic genes was performed for untreated and 5-AzaC
treated  E. histolytica HM-1:IMSS. We chose to perform
expression profiling with the E. histolytica HM-1:IMSS
strain for a number of reasons: (i) this is the strain for
which the genome sequence is available and the array was
designed, (ii) transcriptome data are available for this
strain from an invasive mouse model of colitis and can be
used for comparative purposes [27], (iii) this is the strain
for which there are published data for potential roles of
the retrotransposon elements (long interspersed nuclear
elements (LINEs) and short interspersed nuclear elements
(SINEs)) in amebic pathogenesis and gene silencing
[31,32], (iv) there are substantial genomic differences in
coding and non-coding regions of the 200:NIH strain
compared to HM-1:IMSS [30], and (v) the vast majority of
relevant literature is for the HM-1:IMSS strain.
To identify genes affected by genomic DNA methylation,
we chose to look at both early (3 days) and late (7 days)
time points after 5-AzaC exposure. We chose the early
time point to identify genes that are likely modulated by
5-AzaC as a primary effect (rather than a secondary down-
stream effect of expression changes in other genes). How-
ever, in case certain genomic regions were more resistant
to the effects of 5-AzaC, we also analyzed the parasite tran-
scriptome after seven days of drug exposure. Importantly,
for both these time points, there were no significant
effects on parasite growth rates and both time points gave
consistently attenuated virulence phenotypes in both E.
histolytica strains (Figure 1 and see Additional file 1).
Genes that are endogenously silenced by genomic DNA
methylation should be transcriptionally upregulated
under 5-AzaC treatment. We considered genes transcrip-
tionally regulated if they were modulated at both time
points of 5-AzaC treatment compared to the untreated
controls (overall 2-fold change and p-value < 0.05). To
confirm the array data, a subset of genes whose expression
was modulated by 5-AzaC exposure were tested by semi-
quantitative RT-PCR and in all cases the array data were
confirmed (Figure 2; Table 1). A total of 199 transcripts
(2.1% of all amebic genes tested) were significantly mod-
ulated with 68 genes upregulated and 131 genes down
regulated in 5-AzaC treated parasites compared to control,
untreated parasites (Tables 2, 3, and see Additional File
4). Approximately 58% of these genes were annotated as
hypothetical or of unknown function. Whether all the
genes that were upregulated by 5-AzaC treatment are
methylated or were secondarily controlled by other genes
cannot be definitively stated. However, we required that
genes be transcriptionally modulated at both early andBMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Effects of 5-AzaC on E. histolytica growth and in vitro virulence Figure 1
Effects of 5-AzaC on E. histolytica growth and in vitro virulence. (A) and (B) Growth curves for untreated and 5-AzaC 
treated E. histolytica HM-1:IMSS and E. histolytica 200:NIH strains respectively. On day zero 50,000 trophozoites were inocu-
lated in 15 ml culture tubes and grown with or without 23 µM 5-AzaC. On days two and four (marked by a downward arrow), 
50,000 trophozoites were subcultured into fresh media and 5-AzaC added to the appropriate tubes. (C) Monolayer destruc-
tion of CHO cells by untreated, three-day, and seven-day 5-AzaC treated trophozoites of E. histolytica strains HM-1:IMSS and 
200:NIH. In both parasite strains the 3-day and 7-day 5-AzaC treated parasites showed significantly decreased virulence com-
pared to that with corresponding untreated parasites (p-value < 0.05) (shown by *).
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late time points, thus hopefully minimizing the potential
secondary downstream effects. Genes whose expression
decreases with 5-AzaC treatment are expected to be sec-
ondary or downstream effects of regulation of another
gene. Inhibition of genomic DNA methylation would not,
to the best of our knowledge, be directly expected to
repress gene expression [33].
Genomic regions previously known to be methylated in E.
histolytica are the heat shock protein 100 (EHsp100),
ribosomal RNA (rRNA), and heat shock protein 70
(HSP70), and the repetitive region EhMRS2 [16,18,34].
Of these, the only gene known to be transcriptionally
modulated by DNA methylation is EHsp100 [16]. In the
study by Bernes et al., the EHsp100 gene transcript could
not be detected in untreated E. histolytica HM-1:IMSS par-
asites but was upregulated in 5-AzaC-treated and heat-
shocked parasites [16]. This gene is represented by locus
192.m00086 in the E. histolytica TIGR Genome Database
[35] and represented by the 64.m00187_s_at probe set in
our microarray. However, in our studies this probe set
showed significant hybridization under standard culture
conditions in E. histolytica HM-1:IMSS parasites and was
not modulated by inhibition of DNA methylation (Table
4; see Additional file 4). This probe set was also showed
significant hybridization in the 200:NIH strain (data not
shown). Since this probe set also represented a number of
other genes (111.m00116, 181.m00064, 365.m00018,
482.m00014, 493.m00033, 511.m00026, 82.m00144,
and 872.m00009), we confirmed the array results by RT-
PCR using gene specific primers as designed by Bernes et
al [16]. The RT-PCR analysis, specific to the EHsp100
gene, confirmed our microarray data and indicated that in
our E. histolytica HM-1:IMSS strain the EHsp100 gene
was expressed under baseline culture conditions and was
not modulated by 5-AzaC treatment (see Additional file
2). Other genes associated with the heat shock or stress
response were not expressed in our parasites under stand-
ard culture conditions, indicating that the parasite cul-
tures were not generally stressed (see Additional file 4).
The difference in basal EHsp100 gene expression between
our cultures and those of Bernes, et al. [16] may be due to
differences in the parasite strains. It has been shown that
different clones of E. histolytica HM-1:IMSS have different
expression levels for certain genes, including retrotrans-
posons [31], and have other biologically distinct proper-
ties relating to gene silencing [36].
Using bisulfite treatment followed by sequencing of the
coding and promoter regions we confirmed that the
EHsp100 gene in our parasite strain was methylated
(Table 4). However, the extent of DNA methylation in the
promoter and coding regions of the EHsp100 gene in our
HM-1:IMSS parasite clone was slightly lower compared to
that of Bernes, et al. [16]. For example, position 45 of the
promoter (according to the nucleotide positions referred
to by Bernes, et al., [16]) was found to be unmethylated in
6 out of 6 clones tested in our HM-1:IMSS parasite strain
while 2 out of 5 clones in Bernes' HM-1:IMSS showed evi-
dence of methylation. Similarly, for other positions fewer
clones in our strain showed methylation compared to
their parasites (data not shown). Whether this slight dif-
ference in DNA methylation in our strain compared to
that of Bernes, et al. [16] was responsible for the baseline
higher expression under standard conditions is not clear
at present. While our microarray does not contain probe
sets for rRNA genes, other genes previously known to con-
tain cytosine methylation such as HSP70 (218.m00068)
were not modulated by 5-AzaC treatment. In fact, it has
been shown that the expression of HSP70 is not regulated
by its cytosine methylation [18]; thus, our data are con-
sistent with this observation. We also identified other
genes, whose transcription was marginally modulated
(but which did not meet our 2-fold and p-value < 0.05
cutoff) but whose promoters were methylated
(687.m00016, 3.m00674, 160.m00098, 26.m00304)
(Table 4).
Thus, there appear to be at least two subsets of genes in E.
histolytica. First are those that are endogenously silenced
by genomic DNA methylation and for which 5-AzaC treat-
ment induces significant transcriptional de-repression
(such as 141.m00082, 115.m00143, and 97.m00140).
The second category of genes are those that have genomic
DNA methylation, but are not endogenously silenced
(such as EHsp100, HSP70, 687.m00016, 3.m00674,
160.m00098, 26.m00304) [18]. Whether the second cat-
egory of genes (except for EHsp100 which is sensitive to
5-AzaC treatment) are more resistant to 5-AzaC [37] or are
those in which the methylation profile is not due to meth-
yltransferases but instead due to other factors, such as
dsRNA-directed methylation [38], is not clear at present.
RT-PCR confirmed the array data
In order to confirm the microarray data, we isolated RNA
from 5-AzaC treated and untreated E. histolytica HM-
1:IMSS, and performed semi-quantitative RT-PCR on five
genes: two each from significantly up (115.m00143 and
141.m00082) and down-regulated gene sets (2.m00545
and 226.m00092), respectively, and one invariant gene
(147.m00095), based on Affymetrix analysis. RT-PCR
agreed with the microarray data for all five transcripts
tested (Figure 2).
Genomic DNA methylation apparently silences a small 
subset of amebic genes
Of the total 199 genes modulated in 5-AzaC treated E. his-
tolytica HM-1:IMSS, 68 (0.7% of all amebic genes) were
significantly up regulated by inhibition of genomic DNA
methylation (Table 2). Approximately 72% of these wereBMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Table 1: PCR primers used in study.
(A) Primers used in RT-PCR
Probe set Primer name Direction AT Primer sequence (5' – 3') Target region
115.m00143_at 115.m00143F S 55°C CCAAACGATACACACCCAGA Coding
115.m00143R AS 55°C GCAATTTGAAACTTCACATCACA Coding
141.m00082_at 141.m00082F S 55°C TCATTTGGAATTGTTTATGTTGG Coding
141.m00082R AS 55°C TGCACTTCCAAAATCCGTTA Coding
2.m00545_at 2.m00545F S 55°C GCTGCCATGACTAATGCTGA Coding
2.m00545R AS 55°C AGCAACAGCAACTGGTCCTT Coding
226.m00092_at 226.m00092F S 55°C GCAAACATGGGATACAGCAG Coding
226.m00092R AS 55°C ACAAGGCGCTTGTTCAACTT Coding
(B) Primers used in PCR from bisulfite treated DNA
Probe set Primer name Direction AT Primer sequence (5' – 3') Target region
64.m00187_s_at EHsp5'bis* S 50°C ATGAATAAGAAAGTGTGAATAATAG Promoter
EHsp3'bis* AS 50°C AACATTAATTCCACTATTTCCTACTA Promoter
EHsp1005'* S 50°C TGAGTATTTAAAGGAACTTGAAG Coding
EHsp3'bis* AS 50°C AACATTAATTCCACTATTTCCTACTA Coding
115.m00143_at 115.mPF S 52°C CTTGAAGGATAAAAAATAAGTCATATTTCTA Promoter
115.mPR AS 52°C ATAATCTGCATGGCATATATTTCCTAATT Promoter
115.m00143_at 115.mBCF S 48°C ATGTTTGTATCTTATTTTCTATTTTTAATTT Coding
115.mCR AS 48°C GTTCCAGTACATACAATTTTACCT Coding
141.m00082_at 141.mBPF S 52°C TATTGAACACTGCTCTAAATCCACT Promoter
141.mBPR AS 52°C GTGTAGTACTGAATAAACACTTTTCTT Promoter
141.mBCF S 53°C TTGATATAACTAATTCACCTACATTCCAA Coding
141.mBCR AS 53°C GATCCTTCTCCTATTTTCTTTTCTTCT Coding
97.m00140_at 97.mPF S 50°C ATTACTCCTTCCCTCTCTTCTT Promoter
97.mPR AS 50°C CCATTRTCATTTCTCTCAACC Promoter
194.m00103_at 194.mPF S 50°C GACTRCACCCAATTTTCCACCT Promoter
194.mPR AS 50°C CCATCCCAATAAATTCCTTCTT Promoter
687.m00016_at 687.mBPF S 53°C CTTTCARACACTTAACAAATCTTCTTCA Promoter
687.mBPR AS 53°C ARATTCTCTCAAATACACTTCCCAC Promoter
3.m00674_at 3.mBPF S 49°C GTTATTCAATTATACTTTATACCAAACA Promoter
3.mBPR AS 49°C TCATTTTARTTCTTTTTTCTTATACCACT Promoter
160.m00098_at 160.mBPF S 50°C CTAATAAAATTTTCTTACACCTAACTCA Promoter
160.mBPR AS 50°C CTTCTTTATTTTTTCCATAATATTCTTTCT Promoter
26.m00304_at 26.mBPF S 48°C TAAAACTARACCATTTATTCAACAATT Promoter
26.mBPR AS 48°C RRTTCTTCTTCCATAATTTATTATTA Promoter
2.m00545_at 2.mBPF S 50°C TTACTTCTCGTTATTCTATTAATATAAAC Promoter
2.mBPR AS 50°C GATTATTTTTTGCCATCCATTTATCAA Promoter
2.mBCF S 50°C CTAAATTTACAAAAAAACTAATATACTCTC Coding
2.mBCR AS 50°C TAGAGCCACCATTACATCCATTA Coding
226.m00092_at 226.mBPF S 49°C CTATTGATATTGAAATGCAAAAAACAAT Promoter
226.mBPR AS 49°C TGATATATCAACTTAAACAAACTTACTA Promoter
226.mBCF S 50°C GTTCTTCTAGATTATTAAAAACCATTC Coding
226.mBCR AS 50°C AACACTTCCTTTATCTATTTTATTTCC Coding
Primers used, annealing temperatures, sequences, and their targets (gene promoters or coding regions) are listed for the (A) RT-PCR and (B) 
bisulfite sequencing studies. The probe set targeted, the primer name, direction of the primer, annealing temperature, primer sequence, and region 
of each gene targeted (coding or promoter) are shown. S refers to the sense primer; AS to the antisense primer; R represents either A or G. * 
indicates primers taken from Bernes, et al., 2005 [16].BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Table 2: Genes up-regulated in 5-AzaC treated E. histolytica HM-1:IMSS parasites as compared to untreated controls.
Probe set Baseline expression level Fold-change p-value Annotation
763.m00027_s_ata 0.01 28.97 0.024 hypothetical protein
120.m00098_x_at 0.01 14.35 0.011 hypothetical protein
329.m00054_at 0.01 13.06 0.017 hypothetical protein
253.m00081_x_at 0.02 10.61 0.041 hypothetical protein
16.m00301_at 0.01 9.75 0.006 hypothetical protein
228.m00060_x_at 0.02 9.43 0.007 AIG1 family protein, putative (GO:0004765)
244.m00069_x_at 0.01 9.23 0.021 hypothetical protein
371.m00031_x_at 0.01 8.69 0.006 BspA-like leucine rich repeat protein, putative
295.m00030_at 0.02 8.11 0.036 conserved hypothetical protein
64.m00173_x_at 0.01 7.95 0.043 BspA-like leucine rich repeat protein, putative
94.m00138_at 0.02 7.09 0.033 hypothetical protein
36.m00220_s_atb 0.02 5.78 0.005 hypothetical protein
432.m00029_x_at 0.08 5.32 0.001 conserved hypothetical protein
1087.m00005_at 0.03 5.12 0.038 hypothetical protein
401.m00029_at 1.11 4.97 0.022 protein kinase, putative (GO:0005524)
92.m00177_x_at 0.05 4.39 0.009 hypothetical protein
86.m00156_s_atc 0.09 4.06 0.036 glutamine cyclotransferase, putative
287.m00045_x_at 0.03 3.93 0.026 hypothetical protein
450.m00030_at 0.12 3.90 0.043 hypothetical protein
2.m00587_x_at 0.04 3.83 0.009 hypothetical protein
115.m00143_at* 0.12 3.64 0.001 transcription initiation factor TFIID, putative (GO:0003677)
420.m00021_x_at 0.03 3.59 0.007 hypothetical protein
27.m00245_at 0.03 3.55 0.017 hypothetical protein
103.m00185_at 6.55 3.32 0.023 Fe-hydrogenase, putative (GO:0005489)
194.m00103_at* 0.07 3.27 0.029 protein kinase, putative (GO:0005524)
26.m00274_x_at 0.07 3.22 0.039 hypothetical protein
935.m00010_at 0.11 3.15 0.009 hypothetical protein
93.m00158_s_atd 0.10 3.10 0.014 DNA mismatch repair protein mutS, putative (GO:0006298)
97.m00140_at* 0.08 3.10 0.006 hypothetical protein
138.m00086_x_at 4.75 3.09 0.023 hypothetical protein
66.m00163_s_at 0.03 3.08 0.010 hypothetical protein
12.m00286_at 0.04 3.06 0.025 hypothetical protein
295.m00044_x_at 0.07 3.04 0.017 conserved hypothetical protein
141.m00082_at* 0.32 2.98 0.010 protein kinase, putative (GO:0004672)
267.m00069_at 0.04 2.96 0.001 hypothetical protein
4.m00648_x_at 0.04 2.89 0.032 hypothetical protein
112.m00119_at 0.04 2.85 0.035 hypothetical protein
472.m00058_s_ate 0.08 2.83 0.008 hypothetical protein
204.m00098_x_at 0.22 2.77 0.008 hypothetical protein
583.m00011_at 0.41 2.69 0.026 hypothetical protein
62.m00174_x_at 0.06 2.66 0.037 hypothetical protein
55.m00164_at 0.07 2.63 0.002 hypothetical protein
273.m00075_x_at 0.05 2.59 0.042 hypothetical proteinBMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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249.m00077_x_at 0.06 2.55 0.049 hypothetical protein
289.m00092_at 0.05 2.53 0.014 hypothetical protein
464.m00030_at 0.05 2.53 0.010 hypothetical protein
1.m00665_at 1.11 2.53 0.046 hypothetical protein
51.m00150_x_at 0.05 2.49 0.009 hypothetical protein
159.m00103_x_at 0.43 2.44 0.044 protein kinase, putative (GO:0004672)
19.m00288_at 0.07 2.36 0.005 hypothetical protein
308.m00054_x_at 0.05 2.34 0.009 hypothetical protein
5.m00447_x_at 0.12 2.33 0.016 hypothetical protein
51.m00167_at 0.05 2.33 0.042 hypothetical protein
27.m00266_x_at 0.06 2.30 0.050 ELL complex EAP30 subunit, putative
222.m00072_at 0.09 2.30 0.040 SPRY domain protein
183.m00091_x_at 8.10 2.30 0.026 acyl-CoA synthetase, putative (GO:0008152)
289.m00067_s_atf 0.09 2.30 0.004 short chain dehydrogenase family protein
43.m00197_x_at 7.97 2.24 0.024 cell adhesion protein (GO:0007155)
54.m00234_s_atg 1.09 2.22 0.037 hypothetical protein (GO:0005554)
4.m00613_x_at 0.12 2.21 0.007 hypothetical protein
48.m00224_s_ath 0.71 2.21 0.018 acetyltransferase, putative
75.m00156_x_at 0.11 2.17 0.007 myotubularin, putative
25.m00258_x_at 0.38 2.16 0.032 hypothetical protein
34.m00243_x_at 4.14 2.15 0.028 glucosamine 6-phosphate N-acetyltransferase, putative 
(GO:0008080)
314.m00052_x_at 0.07 2.12 0.041 hypothetical protein
21.m00282_at 0.21 2.08 0.038 hypothetical protein
528.m00022_at 0.10 2.03 0.018 hypothetical protein
48.m00192_at 0.17 2.01 0.013 hypothetical protein
a763.m00027_s_at also represents 190.m00085 (hypothetical protein), 239.m00065 (hypothetical protein), 278.m00067 (hypothetical protein), 
330.m00074 (hypothetical protein), 43.m00171 (hypothetical protein) and 458.m00061 (hypothetical protein)
b36.m00220_s_at also represents 36.m00212 (hypothetical protein)
c86.m00156_s_at also represents 119.m00135 (glutamine cyclotransferase, putative)
d93.m00158_s_at also represents 153.m00091 (DNA mismatch repair protein mutS, putative)
e472.m00058_s_at also represents 361.m00052 (hypothetical protein)
f289.m00067_s_at also represents 180.m00106 (short chain dehydrogenase family protein)
g54.m00234_s_at also represents 169.m00132 (hypothetical protein) and 406.m00049 (hypothetical protein)
h48.m00224_s_at also represents 309.m00047 (acetyltransferase, putative)
The probe set, baseline expression value in untreated E. histolytica HM-1:IMSS trophozoites, fold change in 5-AzaC treated parasites, p-value, and 
gene annotation are shown. Genes in bold are those for which RT-PCR confirmation was performed. Genes in italics are genes whose expression is 
significantly higher in E. histolytica Rahman compared to E. histolytica HM-1:IMSS (p-value 0.0002). Genes with normalized expression values >0.20 can 
routinely be detected by RT-PCR. Genes marked by * are those for which bisulfite sequencing was performed. For annotations, GO IDs are given 
where available and are provided within parentheses.
Table 2: Genes up-regulated in 5-AzaC treated E. histolytica HM-1:IMSS parasites as compared to untreated controls. (Continued)BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Table 3: A subset of genes down-regulated in 5-AzaC treated E. histolytica HM-1:IMSS parasites as compared to untreated controls.
Probe set Baseline expression Fold-change p-value Annotation
Potentially virulence associated
2.m00545_at*£ 4.12 0.27 0.033 cysteine proteinase, putative (GO:0006508)
52.m00148_at 0.96 0.46 0.018 lysozyme, putative
1.m00663_at 6.21 0.36 0.006 myosin calcium-binding light chain, putative (GO:0005509)
Protein kinases
35.m00259_at 1.76 0.48 0.013 protein kinase, putative (GO:0005524)
67.m00091_x_at£ 3.42 0.37 0.033 protein kinase, putative (GO:0005524)
99.m00190_s_at 0.39 0.46 0.040 protein kinase, putative (GO:0006468)
466.m00033_x_at 0.51 0.47 0.003 protein kinase, putative (GO:0005524)
264.m00068_at 2.29 0.44 0.029 protein kinase, putative (GO:0005524)
GTPases
106.m00140_at 2.39 0.48 0.025 Rap Ran GTPase activating protein, putative
2.m00606_x_at 0.20 0.36 0.005 Rab family GTPase (GO:0005524)
226.m00092_at* 0.34 0.44 0.008 Rab family GTPase
30.m00257_at 4.28 0.50 0.023 Rab family GTPase (GO:0005524)
34.m00273_x_at 3.22 0.43 0.040 Rab family GTPase (GO:0005524)
71.m00153_x_at£ 2.21 0.47 0.002 Rho family GTPase (GO:0005525)
8.m00366_s_ata 1.15 0.46 0.021 Rho GTPase activating protein, putative
171.m00089_at 4.88 0.35 0.044 GTPase activating protein, putative (GO:0003924)
Genes with decreased expression in E. histolytica (Rahman) compared to E. histolytica (HM-1:IMSS)
108.m00122_at 32.12 0.21 0.036 hypothetical protein
136.m00107_at 1.20 0.38 0.030 hypothetical protein
22.m00298_at 4.12 0.43 0.002 hypothetical protein
297.m00061_at 5.00 0.35 0.010 hypothetical protein
32.m00239_at 0.93 0.46 0.039 N-acetylglucosaminyl transferase, putative
37.m00215_at 1.90 0.46 0.035 hypothetical protein
442.m00023_x_at 0.82 0.44 0.006 hypothetical protein
460.m00024_s_atb 2.18 0.27 0.015 hypothetical protein
Genes overlap with day-1 & day-29 significantly up-regulated genes from in vivo mouse model (Gilchrist et al, 2006)£
15.m00302_at 4.05 0.41 0.030 hypothetical protein
2.m00545_at* 4.12 0.27 0.033 cysteine proteinase, putative (GO:0006508)
67.m00091_x_at 3.42 0.37 0.033 protein kinase, putative (GO:0005524)
71.m00153_x_at 2.21 0.47 0.002 Rho family GTPase (GO:0005525)
Miscellaneous
338.m00049_s_atc 4.30 0.42 0.020 LIM domain protein (GO:0008270)
10.m00349_x_at 4.30 0.44 0.024 paxillin, putative (GO:0008270)
35.m00253_at 1.74 0.26 0.036 iron-sulfur flavoprotein, putative (GO:0006118)
646.m00021_s_at 0.36 0.40 0.009 iron-sulfur flavoprotein, putative
90.m00179_at 1.31 0.46 0.044 amino acid transporter, putative (GO:0006865)
139.m00118_at 3.90 0.44 0.048 histone H3, putative (GO:0005634)
a8.m00366_s_at also represents 58.m00170 (Rho GTPase activating protein, putative)
b460.m00024_s_at also represents 353.m00048 (hypothetical protein) and 353.m00049 (hypothetical protein)
c338.m00049_s_at also represents 321.m00056 (LIM domain protein)
The probe set, baseline expression value in untreated E. histolytica HM-1:IMSS trophozoites, fold change in 5-AzaC treated parasites, p-value, and 
gene annotation are shown. Genes are clustered according to functional categories. Genes in bold are those for which RT-PCR confirmation was 
performed. Genes with normalized expression values >0.20 can routinely be detected by RT-PCR. Genes marked by * are those for which bisulfite 
sequencing was performed. Genes that were significantly upregulated in E. histolytica HM-1:IMSS trophozoites passed through mice are obtained 
from Gilchrist et al [27] and are indicated by £. For annotations, GO IDs are given where available and are provided within parentheses.BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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annotated as hypothetical proteins. Among the others
were four putative protein kinases (401.m00029,
194.m00103, 141.m00082, and 159.m00103), two BspA-
like leucine rich repeat protein genes (371.m00031 and
64.m00173), transcription initiation factor TFIID
(115.m00143), and a DNA mismatch repair protein gene
(93.m00158). There are two other putative transcription
initiation factor TFIIDs annotated in the E. histolytica
genome (324.m00040 and 40.m00208), both of which
were expressed in detectable levels in untreated HM-
1:IMSS parasites and were not regulated by 5-AzaC treat-
ment (see Additional file 4). It is not clear whether these
two TFIID genes contain genomic DNA methylation. In
contrast, the 115.m00143 gene had very low basal gene
expression and was up regulated in 5-AzaC treated para-
sites, and has genomic DNA methylation of the coding
region (Table 4). To the best of our knowledge, no such
basal transcription factors have been shown to be modu-
lated by DNA methylation in other systems. In prokaryo-
tes DNA methylation is involved in DNA mismatch
repair, and it was interesting to see that the amebic DNA
mismatch repair gene was also regulated by DNA methyl-
ation [39].
Overall, 53 genes went from undetectable baseline expres-
sion (microarray signal < 0.2) to a detectable expression
levels after treatment by 5-AzaC; only 33 genes were up
regulated by ≥ 3-fold, and only 4 up-regulated by ≥ 10-
Verification of array data by RT-PCR Figure 2
Verification of array data by RT-PCR. Array data were confirmed for a subset of genes by semi-quantitative RT-PCR. 
Total RNA was isolated from untreated and 5-AzaC treated parasites (7 days) and subjected to RT-PCR. Sequential 1:10 dilu-
tions of cDNA were used as template for the PCR and a genomic DNA and minus RT control (-RT) were included. The micro-
array expression fold-change for each gene is shown based on average array data from 3 day and 7 day 5-AzaC treated 
parasites. Two genes (115.m00143 and 141.m00082) that were predicted to be upregulated (based on array data) after 5-AzaC 
exposure were confirmed by RT-PCR. Two genes (2.m00545 and 226.m00092) that were predicted to be down-regulated 
(based on array data) after 5-AzaC exposure were confirmed by RT-PCR. A gene whose expression did not change (based on 
array data) with 5-AzaC exposure (147.m00095) was found to be unchanged in the two conditions by RT-PCR. Primers used 
are given in Table 1.
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Table 4: Compilation of bisulfite treatment and sequencing results.
Probe set Baseline 
expression value
Fold change p-value Annotation Promoter region Coding region
Total bp analyzed # methylated cytosines/# 
total cytosines
Total bp analyzed # methylated cytosines/# 
total cytosines
Control genes
64.m00187 14.05 0.90 0.731 Hsp100 455 10/62 397 48/48
64.m00187** 14.05 0.90 0.731 Hsp100** ND ND 397 0/48
Significantly upregulated
141.m00082 0.32 2.98 0.010 protein kinase, putative 308 36/36 73 13/13
115.m00143 0.12 3.64 0.001 transcription initiation 
factor TFIID, putative
266 0/27 254 5/40
97.m00140_at 0.08 3.10 0.006 hypothetical protein 248 59/59 110 23/23
Marginally upregulated
687.m00016_at 12.16 18.68 0.091 hypothetical protein 328 18/18 ND ND
3.m00674_at 0.62 2.17 0.089 hypothetical protein 143 16/16 ND ND
160.m00098_at 11.46 1.72 0.112 hypothetical protein 244 16/16 ND ND
26.m00304_at 0.54 1.64 0.086 hypothetical protein 115 19/19 ND ND
Significantly downregulated
226.m00092_at 0.343 0.34 0.008 Rab family GTPase 347 0/27 41 0/6
64.m00187_s_at also represents 111.m00116, 181.m00064, 192.m00086, 365.m00018, 482.m00014, 493.m00033, 511.m00026, 82.m00144, and 872.m00009.
The probe set, baseline expression value in E. histolytica HM-1:IMSS trophozoites, fold change, p-value, and gene annotation are shown. For each gene the number of base pairs analyzed, the number of 
methylated cytosines, the number of total cytosines analyzed, and the location (promoter or coding region) are indicated. Genomic DNA from E. histolytica HM-1:IMSS parasites was treated with 10 M 
sodium bisulfite and PCR amplified. Six independent clones were analyzed for each region of interest to determine the extent of cytosine methylation; for a particular cytosine position to be indicated as 
methylated 4 out of 6 clones had to be methylated. ** represents genomic DNA from E. histolytica HM-1:IMSS parasites treated with 23 µM 5-AzaC for 7 days. ND = not done. Primers used in PCR analysis 
of the Hsp100 gene were specific to 192.m00086 and were identical to those used by Bernes et al. [16].BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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fold (Table 2). Thus, cytosine methylation apparently
silences a relatively small number of amebic genes. As we
have shown that 23 µM 5-AzaC treatment for seven days
was adequate for inhibiting methylation of the EHsp100
gene (Table 4), we disfavor a technical reason for this
observation. However, we cannot exclude that this para-
site contains other types of rare DNA methylation (ade-
nine methylation or N-4 cytosine methylation) [40-42],
which remained unaffected by 5-AzaC treatment or that
some amebic genomic regions have 5-methylcytosine that
is resistant to 23 µM of 5AzaC treatment. In Arabidopsis
thaliana treatment with 5-Aza-dC resulted in up-regula-
tion of 0.9% of all genes in the array by ≥ 3-fold [26]. This
suggests that DNA methylation silences a relatively small
number of genes in these two systems.
Identification of genomic DNA methylation by bisulfite 
treatment and DNA sequencing
It has been previously shown that the E. histolytica HM-
1:IMSS EHsp100 gene contained methylation in both the
promoter and coding regions [16]. In order to confirm
these data for our E. histolytica HM-1:IMSS strain, we per-
formed a bisulfite reaction followed by strand-specific
PCR of the EHsp100 gene. This procedure converts
unmethylated cytosine residues to uracil, giving rise to
thymine after amplification by PCR [43]. Only methyl-
ated cytosines are refractory to the deamination and are
still seen as cytosines after PCR amplification. We demon-
strated that the EHsp100 gene is methylated at both the
coding and promoter regions and that 5-AzaC treatment
(23 µM for 7 days) significantly inhibited methylation of
this gene (Table 4). The level of demethylation we
observed was similar to that observed by Bernes, et al.
[16]. This confirmed that the 5-AzaC was working as
expected under our usage conditions.
In order to determine the extent of genomic DNA methyl-
ation in genes that were transcriptionally up regulated by
5-AzaC treatment, we performed sodium bisulfite treat-
ment, PCR and sequencing of three genes significantly
upregulated by 5-AzaC treatment (141.m00082,
97.m00140, and 115.m00143). These three genes had
extremely low basal gene expression (0.12 ± 0.07)
(median ± standard error). We identified that two genes
(141.m00082 and 97.m00140) contained cytosine meth-
ylation in both coding and corresponding promoter
regions, while the third one (115.m00143) showed only
limited methylation in the coding region (Table 4). Cyto-
sine methylation in the coding region has been implicated
in gene silencing in other systems [44] and appears to be
responsible for the endogenous silencing of the
115.m00143 gene in E. histolytica. Overall the trend was
for greater methylation in coding than promoter regions,
as also seen by Bernes, et al. [16]. Thus, our microarray
data identified novel genes whose expression was endog-
enously silenced by genomic DNA methylation.
Since the number of genes that were apparently regulated
by DNA methylation was limited, we investigated
whether genes that were somewhat transcriptionally mod-
ulated (but that did not meet our significance fold-change
or p-value criteria) may also be genomically methylated.
Four such genes were subjected to bisulfite treatment and
sequencing: 687.m00016, 3.m00674, 160.m00098, and
26.m00304. We picked genes that were transcriptionally
upregulated early (day 3 of 5-AzaC treatment) (see Addi-
tional file 4) in order to improve our chances of finding
genes partially regulated by methylation. Surprisingly, all
four genes had substantial methylation in their promoter
regions (Table 4). Interestingly, despite the significant
extent of genomic DNA methylation, these four genes
were not transcriptionally silenced under basal conditions
(basal expression levels, 6.04 ± 3.25) (median ± standard
error). A similar trend was previously noticed for the
HSP70 gene, which has genomic methylation, but is not
transcriptionally modulated by DNA methylation [18].
Additionally, in our strain of E. histolytica HM-1:IMSS, the
EHsp100 gene is methylated but not endogenously
silenced or transcriptionally modulated by 5-AzaC treat-
ment (Table 4).
Thus, the extent of genomic DNA methylation in E. histo-
lytica is likely greater than that indicated by the expression
profiling as not all genomic regions that are methylated
appear to be either transcriptionally silenced or substan-
tially regulated by 5-AzaC treatment. We do not feel that
this represents a technical flaw (e.g. the amount of 5-AzaC
used or duration of drug exposure) as 23 µM 5-AzaC for 7
days did completely abolish methylation at the Hsp100
coding region (Table 4). Additionally, higher does of 5-
AzaC (50 µM and higher) are rapidly lethal to the parasite
(our observations and [15]). As mentioned earlier, each
gene that is methylated in E. histolytica does not necessar-
ily respond to 5-AzaC treatment [18]. Similar observa-
tions have also been made in several insect systems. DNA
methylation of defensin gene in the lepidopteran
Mamestra brassicae is not involved in gene silencing as it is
constitutively expressed [45]. Likewise, highly expressed
genes in Myzus persicae [46,47] and Planococcus citri
[48,49] contain DNA methylation.
As expected, a gene whose expression levels significantly
decreased after 5-AzaC treatment showed no cytosine
methylation (226.m00092). Genes whose expression
decreases after exposure to 5-AzaC would not be expected
to be directly transcriptionally modulated by drug treat-
ment, but likely change expression levels as a downstream
effect of other transcriptional changes in the parasites.BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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The majority of genomic DNA methylation in E. 
histolytica is not at CG di-nucleotides
In most systems, genomic DNA methylation occurs at
CpG dinucleotides [50]. The skewed AT content of the
amebic genome (~75% A/T) predicts that methylation
will frequently not occur at CpG dinucleotides [51]. The
majority of methylations we identified were located in
non-CpG sites, confirming previous data for the EHsp100
gene [16]. Non-CpG methylation was also detected in
Entamoeba invadens [52]. In order to determine if we could
bioinformatically predict the location of potential DNA
methylation in E. histolytica genomic DNA, we analyzed
the frequencies of mono- and di-nucleotides in genes
transcriptionally regulated by 5-AzaC compared to the
whole genome. No significant differences in any of the
mono or di-nucleotides were identified in up-regulated or
down-regulated genes compared to the whole genome
(Table 5). Thus, in the E. histolytica genome the frequency
of the mono- or di-nucleotide occurrence was in itself not
predictive of transcriptional regulation by genomic DNA
methylation.
Genes adjacent to retrotransposable elements are not 
substantially silenced by genomic DNA methylation
Retrotransposable elements can have substantial effects
on genome structure and gene expression [53]. One
method by which they can modulate gene expression is by
regulating the expression of adjacent genes by methyla-
tion [54]. Retrotransposable elements are abundant in E.
histolytica and some are maintained in hundreds of copies
per genome [55]. Previously we have identified that two
such retrotransposable elements, LINEs and SINEs, have
higher expression in virulent strains of E. histolytica HM-
1:IMSS compared with nonvirulent Entamoeba [31]. In the
reptile parasite Entamoeba invadens the reverse tran-
scriptase of LINE (RT LINE) contains DNA methylation
and it has been suggested that both E. invadens and E. his-
tolytica  possess a mechanism for DNA methylation of
LINE retrotransposons [52]. It is also not clear how many
fully functional LINE and SINE elements are present in E.
histolytica (the majority of those that are sequenced are
mutated/truncated) but we do know that at least some of
the LINE and SINE elements are transcribed [31].
We were unable to detect the transcriptional profile of
LINEs/SINEs as there are no probe sets representing these
regions in our microarray. We wished to determine if
genes adjacent to LINEs or SINEs were preferentially mod-
ulated by 5-AzaC treatment. The normalized expression
values for all genes adjacent to LINEs or SINEs were 0.761
± 0.09 (median ± std error) and 0.509 ± 0.362 (median ±
std error), respectively, in untreated E. histolytica HM-
1:IMSS, and 0.633 ± 0.207 (median ± std error) and 0.449
± 0.786 (median ± std error), respectively, in 5-AzaC
Table 5: Relative frequencies of mono- and dinucleotides in 5-AzaC modulated genes and in the whole genome.
Whole genome Up-regulated genes Down-regulated genes
Nucleotide Coding Promoter Coding Promoter Coding Promoter
Mononucleotide A 0.36 0.40 0.42 0.40 0.40 0.40
C 0.14 0.11 0.11 0.11 0.11 0.11
G 0.14 0.12 0.16 0.12 0.15 0.12
T 0.36 0.36 0.31 0.37 0.34 0.36
Dinucleotide AA 0.14 0.19 0.18 0.18 0.17 0.19
AC 0.04 0.04 0.04 0.04 0.04 0.04
AG 0.05 0.05 0.06 0.05 0.06 0.05
AT 0.12 0.12 0.12 0.13 0.13 0.12
CA 0.06 0.05 0.06 0.05 0.06 0.05
CC 0.02 0.01 0.02 0.01 0.01 0.01
CG 0.01 0.01 0.01 0.01 0.01 0.01
CT 0.05 0.04 0.03 0.04 0.04 0.04
GA 0.06 0.06 0.08 0.05 0.07 0.05
GC 0.01 0.01 0.01 0.01 0.01 0.01
GG 0.02 0.02 0.02 0.01 0.02 0.01
GT 0.04 0.04 0.04 0.04 0.04 0.04
TA 0.09 0.11 0.09 0.11 0.10 0.11
TC 0.06 0.05 0.04 0.05 0.04 0.05
TG 0.06 0.05 0.06 0.05 0.06 0.05
TT 0.14 0.15 0.11 0.16 0.13 0.16
The frequency of each mono and di-nucleotide was calculated for the entire genome and for the coding and promoter regions of the genes up and 
down-regulated by 5-AzaC. No specific association of any given mono or di-nucleotide frequency with genes that are responsive to 5-AzaC 
compared to the whole genome was identified.BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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treated E. histolytica HM-1:IMSS. Thus, we did not identify
any significant association of genes that were modulated
by 5-AzaC and their genomic proximity to LINE or SINE
elements compared with untreated parasites. This finding
indicates that even if the LINE/SINE elements in E. histo-
lytica contain DNA methylation they do not necessarily
co-regulate adjacent genes by this mechanism.
Additionally, we identified that adjacent loci in the same
scaffold did not show co-regulation by DNA methylation
(data not shown). This phenomenon is also observed in
Arabidopsis thaliana, in which transcriptional profiling
reveals that 5-Aza-dC responsive genes are distributed ran-
domly throughout the chromosome arms and are not
clustered in any obvious pattern [26].
Effect of 5-AzaC on E. histolytica virulence
Virulent strains of E. histolytica HM-1:IMSS and 200:NIH
grown with 23 µM of 5-AzaC for three or seven days
showed no substantial growth differences but displayed
severely reduced virulence phenotype compared to
untreated parasites (Figure 1) [15]. Importantly, others
have demonstrated that the effect of 5-AzaC on parasite
virulence is reversible and parasite virulence returns to
baseline when drug exposure is withdrawn [15]. Whether
the effect of 5-AzaC on parasite virulence is simply an
associative or causal finding is unclear at present. How-
ever, we did find some genes that were down regulated in
5-AzaC treated parasites, which have previously been
shown to function as virulence determinants (Table 3).
These included a putative cysteine proteinase
(2.m00545), lysozyme (52.m00148), and a myosin Ca-
binding protein (1.m00663). Cysteine proteinases (CP)
are important virulence determinants in E. histolytica and
serve a number of functions including degradation of
colonic mucin and extracellular matrix [56]. Genetic
proof of their importance in virulence has been shown as
parasites in which members of the CP family are down
regulated are less virulent in vitro and in vivo [57,58]. Lys-
ozymes are important for degrading intracellular bacteria
and thus play an important role in E. histolytica virulence
[59]. Motility is an important aspect of amebic pathogen-
esis and parasites that are altered in their myosin II are less
virulent [60]. Likewise, Toxoplasma gondii myosin A has
been implicated in powering parasite gliding and host cell
invasion [61]. In addition, five protein kinase genes and
eight GTPase family protein genes were also down regu-
lated significantly in 5-AzaC treated parasites. Protein
kinases can affect the functions of a large number of genes
and the GTPase gene family is important in vesicle traf-
ficking, an important aspect of biology in the profession-
ally phagocytic E. histolytica [62]. Thus, some roles of these
genes in amebic pathogenesis can be anticipated,
although functional genetic proof will be necessary to
assign a definitive role to these genes in amebic virulence.
Importantly, eight of the genes down regulated under 5-
AzaC treatment also had decreased expression in a non-
virulent strain of E. histolytica, Rahman, compared to the
virulent  E. histolytica HM-1:IMSS (108.m00122,
136.m00107, 22.m00298, 297.m00061, 32.m00239,
37.m00215, 442.m00023, and 460.m00024) (Table 3)
[31,63]. Interestingly, in E. histolytica Rahman, treatment
with 23 µM 5-AzaC did not significantly change the tran-
scriptional profile of these genes (data not shown). A
number of genes that have decreased expression in aviru-
lent Entamoeba strains and species have been shown to be
virulence determinants including the Gal/GalNAc light
subunit lectin [64], CP1 and CP5 [56-58], and amebapore
[32]. In addition, four genes down regulated by 5-AzaC
treatment (15.m00302, 2.m00545, 67.m00091, and
71.m00153) are significantly up regulated during parasite
invasion in a mouse model of amebic colitis (Table 3)
[27]. Since E. histolytica trophozoites passed through a
mouse model become more virulent, some of the upregu-
lated genes from the in vivo mouse model of colitis may
have direct roles in virulence. Thus, data from a number
of different angles indicates that genes that are down reg-
ulated by 5-AzaC treatment are good candidates on which
to perform directed functional studies to elucidate their
potential contributions to amebic virulence.
Discussion
Cytosine methylation is the most frequent endogenous
modification of DNA in eukaryotes and is involved in reg-
ulating gene expression [1]. DNA methylation has been
implicated as having a multitude of effects in Entamoeba
histolytica, however, the extent of DNA methylation and its
overall roles in epigenetic gene silencing in this parasite
were unknown. Here we report for the first time whole
genome transcriptional profiling of E. histolytica parasites
treated with 5-AzaC, an inhibitor of DNA methyltrans-
ferase. Our findings indicate that 68 genes (about 0.7% of
tested genes) are endogenously silenced by methylation
in this parasite.
We identified DNA methylation in the coding regions of
some E. histolytica genes and in some instances higher lev-
els of cytosine methylation in the coding regions com-
pared to the promoter regions. In the transcription
initiation factor TFIID gene (115.m00143) we only iden-
tified methylation in the coding region and yet this gene
was transcriptionally silenced by endogenous methyla-
tion. This is consistent with the observation that DNA
methylation within the body of genes may also have a
dampening effect on transcriptional elongation. It has
been suggested that methyl binding proteins might be
involved in inhibiting elongation, either directly or by
their effects on the surrounding chromatin structure [44].
A recent report of DNMT2 protein having a novel tRNA
methyltransferase activity in mouse, Arabidopsis, and Dro-BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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sophila suggests that the biological role of this protein is
broader than was previously anticipated [65]. Interest-
ingly, the cytoplasmic localization of the DNMT2 protein
in mammalian cells is in contrast to the nuclear localiza-
tion seen in E. histolytica [15]. It is not currently known
whether the E. histolytica DNMT2 may also have a tRNA
methyltransferase activity.
The E. histolytica genome is littered with retrotransposon
elements of the LINE and SINE category. As a measure of
genome defense, organisms often methylate these ele-
ments (and adjacent genes) in an attempt to silence them
and prevent adverse effects of random transposition
(reviewed in [3]). Our analysis indicates that in E. histolyt-
ica HM-1:IMSS genomic regions adjacent to the LINE and
SINE elements are not significantly modulated by treat-
ment with 5-AzaC. However, methylation of some LINE
elements in Entamoeba have been reported and a DNA
methylation based mechanism for controlling these ele-
ments is anticipated [52]. Thus, either the methylation is
specific to the LINE elements (which we were not able to
address in our analysis as the arrays do not contain probes
for these regions) and does not spread to adjacent
genomic regions, or the adjacent loci have a methylation
pattern that is resistant to 23 µM 5-AzaC treatment. Addi-
tionally, although a LINE element was identified as being
methylated (initially isolated using affinity chromatogra-
phy and an anti-5-methyl cytosine antibody) attempts to
identify a specific genomic copy of the LINE element that
is methylated in E. histolytica have been unsuccessful to
date [52]. Taken together the data indicate that methyla-
tion is involved to some degree in controlling LINEs in E.
histolytica, but is likely not a genome-wide phenomenon
and that other mechanisms to control retrotransposition
in E. histolytica likely exist.
Despite the relatively few changes in gene expression
induced by 5-AzaC treatment (68 genes upregulated and
131 genes down-regulated), there was marked reduction
in monolayer destruction by two virulent strains of E. his-
tolytica (HM-1:IMSS and 200:NIH). Since the two parasite
strains are genetically distinct [30] and have unique
expression profiles [63], the consistent effects of 5-AzaC
treatment on amebic phenotype are interesting. Thus,
genes that had differential expression in 5-AzaC treated
parasites (especially those whose expression decreased by
5-AzaC treatment) deserve further directed functional
studies to characterize their potential roles in parasite vir-
ulence. Importantly, it has previously been reported that
the decrease in parasite virulence by exposure to 5-AzaC
was reversible upon removal of the drug, suggesting that
drug exposure likely did not impart significant permanent
mutations in the E. histolytica genome [15].
Our findings indicate that, although DNA methylation is
operational in E. histolytica, this epigenetic mechanism of
gene expression regulation affects a relatively small por-
tion of amebic genes.
Conclusion
DNA methylation has roles in many crucial biological
functions including regulation of gene expression. The
genome-wide extent of DNA methylation and its subse-
quent effects on gene expression are unknown in many
eukaryotes. We investigated the effects of DNA methyla-
tion in the protozoan parasite Entamoeba histolytica using
whole genome expression profiling of parasites treated
with 5-azacytidine, a potent inhibitor of DNA methyl-
transferase. Drug treatment modulated the expression of
~2.1% of all amebic genes including 68 genes that were
up-regulated and 131 genes that were down regulated.
Methods
Parasite culture, 5-AzaC treatment, and growth curves
Trophozoites of E. histolytica HM-1:IMSS and E. histolytica
200:NIH were maintained under axenic conditions in
trypticase-yeast extract iron-serum medium (TYI-S-33)
supplemented with 15% adult bovine serum (Sigma), at
36.5°C as previously described [66]. The identity of both
strains was confirmed by strain-specific PCR and RFLP
analysis [67]. Trophozoites in log phase of growth were
used in all experiments. To inhibit genomic DNA methyl-
ation, E. histolytica trophozoites were grown with 23 µM 5-
AzaC (TRC, Canada) for up to one week with routine sub-
culturing performed every 48 hours. For the growth curves
50,000 log-phase trophozoites were inoculated in 15 ml
of TYI-S-33 media in the presence or absence of 23 µM 5-
AzaC, grown under standard culture conditions as out-
lined above, and the parasite number recorded every 24-
hours. Growth curves were performed a minimum of
three times. To grow parasites without subculturing, we
seeded 15,000 log-phase trophozoites in 15 ml of TYI-S33
media in the presence or absence of 23 µM 5-AzaC under
standard culture conditions and monitored the parasite
count every day up to day 5. In order to further assess the
growth kinetics of the parasites in 23 µM 5-AzaC, 50,000
log-phase trophozoites were seeded in 15 ml of TYI-S33
media in the presence or absence of 23 µM 5-AzaC and
subcultured every two days with equal inoculums of
media and parasites being passed each time. Cell counts
were recorded at days 2, 4, and 6 after initiation of growth
in 5-AzaC.
Protein concentration determination
Protein concentration was determined using the method
of Bradford [68]. Briefly, trophozoites were lysed on ice
for 2 min using Cell Culture Lysis Reagent (Promega) sup-
plemented with protease inhibitors (500 µM AEBSF, 1 µM
leupeptin, 1 µM E-64d). Cell membranes were pelleted byBMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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centrifugation for 30 sec at 14,000 × g. A standard curve
for the Bradford assay was determined using bovine
serum albumin as a reference. Protein concentration of
the cell lysate was determined relative to this standard
curve. The protein concentration (ng/cell) was deter-
mined for each time point of interest.
Chinese Hamster Ovary (CHO) cell culture and in vitro 
CHO cell monolayer destruction assay
CHO cells were maintained in Dulbecco's minimal essen-
tial media (DMEM) supplemented with 10% fetal bovine
serum, penicillin (100 U/ml), and streptomycin (100 µg/
ml). CHO cell monolayer destruction by E. histolytica tro-
phozoites was performed according to Bracha and Mirel-
man [69] with some modifications. Briefly 200,000
trophozoites of E. histolytica strain HM-1:IMSS or
200:NIH grown with or without 23 µM of 5-AzaC for
three or seven days were incubated with confluent CHO
cell monolayers in 24-well plates in 3 mls of DMEM (con-
taining no serum) at 36.5°C for 3 hours. The integrity of
the CHO cell monolayer that remained attached to the 24-
well plate was determined by staining with methylene
blue. The level of monolayer destruction was calculated to
be inversely proportional to the amount of intact cells that
remained attached to the 24-well plate. CHO cells incu-
bated with DMEM or DMEM with 23 µM 5-AzaC served
as controls. All experiments were performed at least three
times. Statistical analyses were performed using a two-
tailed Student's t-test and p-values < 0.05 were considered
statistically significant.
Microarray expression profiling
A custom E. histolytica Affymetrix array (E_his-1a520285)
was designed using information from the E. histolytica
genome sequencing project [27]. The ORF probe sets rep-
resent 9,435 of the predicted 9,938 E. histolytica ORFs
[70]. Most of the highly repetitive sequences in E. histolyt-
ica such as LINEs, SINEs, rRNA genes, and tRNA genes
were not included in the array as specific probe sets could
not be designed. There are probe sets on the Affymetrix
array representing selected intergenic regions, but these
were not included in the analyses described in this paper.
Total RNA was isolated from log phase trophozoites of E.
histolytica HM-1:IMSS and the same strain grown with 23
µM 5-AzaC for three or seven days using Trizol reagent
(Invitrogen). RNA was cleaned using the RNAeasy kit
(QIAGEN) according to the manufacturer's instructions
and 4 µg processed for hybridization to the E. histolytica
Affymetrix array through the Stanford University Protein
and Nucleic Acid Biotechnology Facility [71] using stand-
ard Affymetrix protocols. Two arrays were generated for
HM-1:IMSS parasites (not treated with drug) under mid-
log conditions and two arrays were generated from HM-
1:IMSS parasites treated with 5-AzaC (one each from three
and seven days of treatment). Each microarray was gener-
ated from RNA harvested from parasites on different days
and thus represent independent biological replicates.
Microarray data analysis
The raw signal intensities were scaled by GCOS software
so that the average of all of the probe sets on an array was
500. All data for intergenic regions was removed prior to
any further analysis. The remaining data were analyzed
using the GeneSpring® 7 software [72]. A global normali-
zation was performed per chip to the median excluding
the probe sets flagged absent. All the normalized expres-
sion values were averaged between the two arrays from
untreated parasites (control group), and between the two
arrays from three day and seven day 5-AzaC-treated para-
sites (treated group). We assumed that the expression var-
iances were equal for two arrays within a particular group.
To eliminate genes that were not expressed under either of
the two conditions, we filtered out probe sets that had an
average normalized expression value of < 0.1 in both
groups analyzed (control and 5-AzaC-treated) as we have
previously determined that genes with that expression
level are not routinely detectable by RT-PCR (our unpub-
lished observations). In order to identify genes that were
significantly modulated in presence of 5-AzaC we used
two criteria: (1) expression fold change ≥ 2-fold, and (2) a
p-value < 0.05.
RNA isolation and RT-PCR
Total RNA was extracted from log phase E. histolytica HM-
1:IMSS parasites using TRIZOL (Invitrogen) reagent
according to the manufacturer's instructions. DNA con-
tamination in the RNA preparation was removed by
DNAse treatment. Reverse transcription was performed to
generate cDNA for RT-PCR using SuperScript™ II Reverse
Transcriptase kit (Invitrogen) according to the manufac-
turer's instructions. PCR was performed with serial 10-
fold dilutions of cDNA; a negative control was included
with each reaction. Primers used in RT-PCR are listed in
Table 1.
Sodium bisulfite treatment and PCR amplification
E. histolytica HM-1:IMSS genomic DNA was isolated using
standard Phenol:Chloroform method, and RNA contami-
nation was removed by treating with RNaseA (Invitrogen)
[30]. Sodium bisulfite treatment of E. histolytica genomic
DNA (~2 µg) was performed according to the method
described by Clark and Warnecke [43]. For each sample,
following bisulfite treatment, two PCR amplifications
were performed, each consisting of 50 cycles. Primers
used to amplify promoters and genomic regions following
bisulfite treatment are listed in Table 1. PCR amplified
fragments derived from sodium bisulfite treated DNA
were resolved on a 1.2% agarose gel, appropriate frag-
ments excised and purified using QIAEX® II Gel ExtractionBMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Kit (QIAGEN) according to the manufacturer's instruc-
tions. Purified DNA fragments were cloned into TOPO TA
vector (Invitrogen), transformed into competent
Escherichia coli (Invitrogen), plasmid DNA isolated using
QIAprep Miniprep Kit (QIAGEN), and sequenced using
an ABI PRISM 310 genetic analyzer (PE Applied Biosys-
tems) (Macrogen, Korea). Six plasmid clones were
sequenced for each gene fragment.
Genome structure analysis of genes modulated by 5-AzaC 
treatment
In order to determine the frequency of mono and di-
nucleotides in the genomic regions affected by 5-AzaC
treatment we performed the following analysis.
Sequences for the promoter (500 bp upstream of the pre-
dicted start codon) and coding regions of all genes modu-
lated by 5-AzaC treatment were downloaded from The
Institute for Genomic Research (TIGR) website [35]. Addi-
tionally, the sequence of the most recent assembly (12/
27/05) of the genome sequence was also obtained [35].
Using acustom script written in the Python programming
language by JAH (see Additional file 3) we determined the
mono and di-nucleotide frequency in the promoter and
coding regions of genes up-regulated by 5-AzaC treat-
ment, down-regulated by 5-AzaC treatment, and the
entire genome.
To determine if the genes modulated by 5-AzaC treatment
were adjacent to the retrotransposon elements (LINEs and
SINEs), all occurrences of the three families of EhLINEs
and EhSINEs were identified in the E. histolytica genome
sequence using BLAST program [73] and the consensus
sequence of the LINEs and SINEs [55] with an e-value cut-
off of 10-20. The frequency of occurrence of each LINE and
SINE gene family member was similar to the results iden-
tified previously [55]. We subsequently identified all
genes adjacent (within 10 Kb, both upstream and down-
stream) to each member of EhLINE or EhSINE, consider-
ing only the gene most proximal to a given LINE or SINE.
Using the hypergeometric distribution, we determined if
the genes modulated by 5-AzaC treatment were more
likely to be adjacent to an EhLINE or EhSINE element
than by random chance (p-value < 0.05).
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5-AzaC, 5-azacytidine; 5-Aza-dC, 5-aza-2-deoxycytidine;
PCR, polymerase chain reaction; RT-PCR, reverse-tran-
scription-PCR; LINE, long interspersed nuclear element;
SINE, short interspersed nuclear element; Ehmeth, Enta-
moeba histolytica methyltransferase; DNMTs, DNA methyl-
transferases; MBD, Methyl binding domain; m5C, C5-
cytosine; DMEM, Dulbecco's minimal essential media;
CHO, Chinese Hamster Ovary; ORF, open reading frame.
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Additional material
Additional File 1
(A) E. histolytica HM-1:IMSS grown in 23 µM 5-AzaC for five consec-
utive days have similar growth kinetics to untreated parasites. E. histolyt-
ica HM-1:IMSS log-phase trophozoites (15,000) were seeded into 15 ml 
glass culture tubes, cultured under standard conditions ± 23 µM 5-AzaC, 
and cell counts taken at days 2, 3, 4, and 5. The average and standard 
deviation values for each time point are shown for untreated and 5-AzaC 
treated parasites. There were no statistical differences in the cell counts at 
any given time point in 5-AzaC treated and untreated parasites. One rep-
resentative experiment is shown. (B) Protein content per cell was deter-
mined at days 2, 3, 4, and 5 of parasite growth ± 23 µM 5-AzaC 
treatment for E. histolytica HM-1:IMSS parasites. The average and 
standard deviation values for each time point are shown. There were no 
statistically significant differences in the protein concentration per cell at 
any given time point in 5-AzaC treated and untreated parasites or in par-
asites grown for 2, 3, 4, or 5 days. One representative experiment is 
shown. (C) E. histolytica HM-1:IMSS grown in 23 µM 5-AzaC for six 
days with routine subculturing of equal volume of media/parasites have 
similar growth kinetics to untreated parasites after two days in 5-AzaC. E. 
histolytica HM-1:IMSS log-phase trophozoites (50,000) were seeded 
into 15 ml glass culture tubes and cultured under standard conditions ± 
23 µM 5-AzaC. At days 2 and 4 (marked with a down arrow) an equal 
volume of media containing parasites grown ± 5-AzaC was inoculated 
into a new tube with fresh media (± 5-AzaC) and cell counts obtained at 
days 2, 4, and 6. The average and standard deviation values for each time 
point are shown for untreated and 5-AzaC treated parasites. One repre-
sentative experiment is shown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-7-S1.doc]
Additional File 4
Normalized expression values for arrays from untreated and 5-AzaC 
treated E. histolytica HM-1:IMSS parasites. All array data have been 
made available per MIAME guidelines. Raw array data have been depos-
ited at the NCBI Gene Expression Omnibus website (accession number 
GSE6635).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-7-S4.xls]
Additional File 2
Verification of array data for EHsp100 (represented on the microarray by 
the probe set 64.m00187_s_at) by semi-quantitative RT-PCR. Total RNA 
was isolated from untreated and 5-AzaC treated parasites (7 days) and 
subjected to RT-PCR. Sequential 1:100 dilutions of cDNA were used as 
template for the PCR and a genomic DNA and minus RT control (-RT) 
were included. The microarray expression fold-change for each gene is 
shown based on average array data from 3-day and 7-day 5-AzaC treated 
parasites. Primers specific to the EHsp100 gene (192.m00086) as deter-
mined by Bernes et al [16] were used for the RT-PCR reaction. A gene 
whose expression did not change based on array data (147.m00095) was 
found to be unchanged in the two conditions by RT-PCR.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-7-S2.ppt]BMC Genomics 2007, 8:7 http://www.biomedcentral.com/1471-2164/8/7
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Additional File 3
This Python script determines the frequencies of mono- and dinucleotides 
in a FASTA sequence file. This program requires a Python interpreter 
installed on the computer that is being used for this analysis, which can 
be freely downloaded [74]. Download the text of this file exactly as writ-
ten (including white space). To run the program, type "python <name of 
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